Abu Dhabi-based startup Ovasave which focuses on addressing women’s health needs has raised $1.2m in pre-seed funding to scale its digital platform for fertility and hormonal health.
The round was led by PlusVC, Annex Investments, and New York-based 25 Madison, with additional backing from regional angel investors and family offices in the UAE and Saudi Arabia.
Founded in 2023, Ovasave operates out of Hub71 and offers a comprehensive, tech-enabled platform that includes at-home hormone testing, virtual consultations, personalised supplement plans, and coordinated access to fertility clinics for egg freezing. It also runs a growing corporate benefits programme aimed at improving reproductive health support in the workplace.
Gulf Economist Staff Writer